ReviewExpert review of anticancer therapy2009
Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms.
Ehab Atallah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewExpert review of anticancer therapy2009
Ehab Atallah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.